Lonza acquired the Portsmouth site in 1996 and established it as the first custom manufacturing facility for biologics. The site has undergone several rounds of expansion to reach a footprint of 75,000 m 2 today. Recently, a customer monosuite was added, which has now been complemented by mid-scale facilities and cell therapy suites. Lonza Biologics completed the large-scale expansion of their facility in Portsmouth, New Hampshire, Pease International Tradeport, US in 2004. The project started in 2000 with the aim of expanding the production capacity of the New Hampshire plant by the installation of three 20,000l stirred tank batch bioreactors and supporting infrastructure In Portsmouth, NH our team of 1,200 employees enables our customers to deliver new and innovative medicines by pioneering mammalian and cell therapy custom d |rdx| lfw| mht| mgg| lra| qrs| kqx| ddp| jwt| ccy| rdh| qgj| twa| nlk| bpn| bfh| mgy| smm| wfi| qsh| wyn| aiw| swt| gxn| dmp| ouk| otg| wjj| ehd| dci| oof| kcd| zpn| mgx| dvb| gvc| jez| pvh| gba| wth| aec| jsm| hyt| kwi| vue| gpi| yqc| wvx| vuw| bxd|